AgaMatrix
Salem
About AgaMatrix
AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care. The company’s products feature WaveSense, a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. Zero-Click™, the WaveSense diabetes data management system, was designed to simplify data download. WaveSense and Zero-Click consist of six FDA-cleared products and are protected by a suite of more than 160 patents worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $152.2M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2019)
- Website: agamatrix.com
- Phone: (603)328-6000
Industries & Categories
Diabetes, Health Care, Manufacturing, Medical Device, Mobile Apps
Social Profiles
Canonical: https://fsome.com/organization/agamatrix-6292 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.